AVITA Medical, Inc.
Price Action
Technical Summary
CONSOLIDATINGAVITA Medical, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 77), indicating performance broadly in line with the market. Earnings growth of 34% provides fundamental context to the price action. However, price is extended 22% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.17 | +24.51% | ABOVE |
| 50 SMA | $4.26 | +21.71% | ABOVE |
| 100 SMA | $4.38 | +18.63% | ABOVE |
| 150 SMA | $4.15 | +25.10% | ABOVE |
| 200 SMA | $4.24 | +22.36% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is RCEL in an uptrend right now?
RCEL has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is RCEL overbought or oversold?
RCEL's RSI (14) is 72. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is RCEL outperforming the market?
RCEL has a Relative Strength (RS) Rating of 77 out of 99. RCEL is performing about average compared to the market.
Where is RCEL in its 52-week range?
RCEL is trading at $5.19, which is 73% of its 52-week high ($7.12) and 51% above its 52-week low ($3.22).
How volatile is RCEL?
RCEL has a Beta of 1.76 and 52-week volatility of 91%. It's more volatile than the S&P 500 - expect bigger swings.